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Rheb, a ubiquitous small GTPase, is well known to
bind and activate mTOR, which augments protein
synthesis. Inhibition of protein synthesis is also
physiologically regulated. Thus, with cell stress, the
unfolded protein response system leads to phos-
phorylation of the initiation factor eIF2a and arrest
of protein synthesis. We now demonstrate a major
role for Rheb in inhibiting protein synthesis by
enhancing the phosphorylation of eIF2a by protein
kinase-like ER kinase (PERK). Interplay between the
stimulatory and inhibitory roles of Rheb may enable
cells to modulate protein synthesis in response to
varying environmental stresses.INTRODUCTION
Protein synthesis is orchestrated by an array of proteins, which
activate or inhibit translation based on their phosphorylation
status. The mTOR system enhances protein synthesis in
response to nutrients and growth factors. Cellular stress, on
the other hand, triggers processes that inhibit translation in order
to conserve cellular resources. Phosphorylation of eukaryotic
translation initiation factor 2a (eIF2a) is a major mediator of this
inhibitory system and involves four discrete kinases: protein ki-
nase-like ER kinase (PERK), general control nonderepressible
2 (GCN2), protein kinase RNA-activated (also known as protein
kinase R; PKR), and the heme-regulated inhibitor (HRI) (Donnelly
et al., 2013).
There exists an inverse relationship between mTOR signaling
and phospho-eIF2a. Under pathological conditions, such as
apoptosis, hypoxia, serum, and nutrient deprivation, mTOR ac-
tivity is downregulated whereas phospho-eIF2a is upregulated,
leading to diminished global protein synthesis (Deng et al.,
2002; Hara et al., 1998; Kim et al., 2002; Koumenis et al., 2002;684 Cell Reports 10, 684–693, February 10, 2015 ª2015 The AuthorsLiu et al., 2006; Schneider et al., 2008; Tee and Proud, 2001).
In some instances, mTOR and eIF2a may act in parallel. For
example, deletion of TSC2, an inhibitor of mTOR signaling,
augments signaling both by mTOR and by phospho-eIF2a
(Ozcan et al., 2008). Pharmacologic and genetic studies suggest
that mTOR signaling does influence phospho-eIF2a. For
instance, the mTOR inhibitor rapamycin is known to upregulate
phospho-eIF2a in some cells (Anand and Gruppuso, 2006;
Kato et al., 2012; Kubota et al., 2003; Matsuo et al., 2005). Simi-
larly, heat inactivation of mTOR potentiates phospho-eIF2a in
yeast cells, whereas the genetic deletion of PTEN, a negative
regulator of mTOR, reduces phospho-eIF2a in cancerous cells
(Mounir et al., 2009; Valbuena et al., 2012).
The GTPase Rheb is well established as an inducer of mTOR
thereby augmenting protein synthesis. Here, we demonstrate
that Rheb plays a major role in inhibiting protein synthesis by
enhancing PERK-mediated phospho-eIF2a levels. This action
may underlie, in part, the reciprocal relationship of mTOR and
eIF2a signaling.
RESULTS
GTPase Rheb Inhibits Protein Synthesis
The canonical mTOR pathway involves TSC1/2 binding to and
inhibiting Rheb, preventing activation of mTOR signaling by
Rheb (Inoki et al., 2003). Rheb, acting via mTOR, is generally
regarded as a physiologic stimulant of protein synthesis (Hall
et al., 2007; Wang et al., 2008). By contrast, in human embryonic
kidney 293 (HEK293) cells, we observe that overexpression
of Rheb is associated with diminished protein synthesis, as
measured by incorporation of [35S]-Met (Figure 1A). Tunicamy-
cin, an ER stressor, elicits cell stress and inhibited protein
synthesis (Figure 1A).We confirm that overexpressing Rheb aug-
ments phospho-S6 kinase, an index of mTOR signaling (Fig-
ure S1). The marked stimulation by tunicamycin of CHOP, an
apoptotic protein, confirms its stressor actions (Figure S1). How-
ever, Rheb overexpression does not affect CHOP levels (Fig-
ure S1), indicating that diminished incorporation of [35S]-Met
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by Rheb (Figure 1A) may not be due to cellular stress. Inhibition
of protein synthesis by Rheb is dependent upon its guanine-
nucleotide binding, as it is absent with Rheb-D60K (Figure 1B),
which cannot bind guanosine triphosphate (GTP) or guanosine
diphosphate (Aspuria and Tamanoi, 2004). Polysome profiles re-
vealed the Rheb wild-type (WT)-overexpressing cells showed a
reduced polysome/monosome ratio (Figure 1C). We next as-
sessed whether Rheb can directly modulate protein synthesis
in vitro (Figure 1D). Rheb WT, but not Rheb D60K, markedly de-
creases luciferase mRNA translation, an effect also elicited by
active PERK kinase, a known inhibitor of protein synthesis (Har-
ding et al., 1999). Rheb overexpression increased the viability of
the HEK293 cells in an MTS ([3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium]; in-
ner salt) assay (which measures mitochondrial activity), but it
did not significantly alter the cell number (counted using a hemo-
cytometer) (Figure S2). In TSC2 depleted fibroblasts, which
possess high Rheb–mTOR activity (Inoki et al., 2003; Zhang
et al., 2003), weobserve diminished protein synthesis (Figure 1E),
consistent with previous report compared to TSC2 intact cells
(Auerbach et al., 2011). TSC2 depleted fibroblasts also exhibited
reduced polysome/monosome ratio (Figure 1F) and diminished
cell numbers, compared to TSC2 intact cells (Figure S3).
Thus, GTPase Rheb can act as a negative regulator of protein
synthesis.
Rheb Enhances the Phosphorylation of eIF2a, which
Inhibits Protein Synthesis
By what mechanism might Rheb inhibit protein synthesis? We
examined regulation of eIF2a, whose phosphorylation is associ-
ated with inhibition of protein synthesis (Harding et al., 1999).
Overexpressing Rheb (2- to 4-fold more than endogenous
Rheb) in the absence or presence of serum markedly stimulates
phosphorylation of eIF2a at serine-51 with an increase com-
parable to the stimulation of mTOR signaling monitored as
phospho-S6 kinase/phospho-4EBP1 (Figure 2A). This action of
Rheb is dependent upon its guanine-nucleotide binding, as
levels of phospho-eIF2a, like those of phospho-S6 kinase and
phospho-4EBP1, are markedly reduced in the presence of
Rheb-D60K (Figure 2B).
Rheb influences phospho-eIF2a levels in intact animals. Thus,
injections of adeno-associated viral particles expressing Rheb
directly into the hippocampus elicit a substantial increase in
phospho-eIF2a and phospho-S6 kinase (Figure 2C). Further ev-
idence that Rheb is required for phosphorylation of eIF2a comes
from experiments depleting Rheb by small hairpin RNA (shRNA)
leading to a profound reduction in phospho-eIF2a as wellFigure 1. Rheb Inhibits Protein Synthesis
(A) Autoradiography of [35S]-Met incorporation and total protein levels (ponceau s
treated (100 nM) cells were used as a control.
(B) Autoradiography and total protein levels (ponceau staining) of HEK293 cells e
(C) Polysome profiles of myc-, Rheb WT-, and Rheb D60K-expressing HEK293 c
(D) Autoradiography of a rabbit reticulocyte-based in vitro translation assay in th
(KD) (50 ng), GST-PERK-DKD (50 ng), GST-Rheb WT (500 ng), or D60K (500 ng)
(E) Autoradiography and total protein levels of TSC2+/+ and TSC2/ MEFs pulse
(F) Polysome profiles of TSC2+/+ and TSC2/ MEFs. P/M, polysome/monosome
**p < 0.01; *p < 0.05; n.s, not significant (Student’s t test). Data are means ± SEM
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altered the protein expressions of eEF2, the target of mTORC1
signaling (Browne and Proud, 2002; Hay and Sonenberg,
2004), and ATF-4, the target of phospho-eIF2a signaling (Lu
et al., 2004). While Rheb-WT overexpression increased the
eEF2/ATF-4 protein levels, Rheb shRNA treatment attenuated
those levels (Figures S4A–S4D). Note that although ATF-4 levels
go up, CHOP, one of the ATF-4 target genes, is not increased
(Figure S1). Although mechanisms are unclear, CHOP can also
be induced through ATF-4-independent pathways. It has been
shown that ATF-4/ mouse embryonic fibroblasts (MEFs) elicit
CHOP expression induced by thapsigargin (Ma and Hendershot,
2004) and that ATF-4 is necessary, but not sufficient, for the in-
duction of CHOP expression under certain conditions (Harding
et al., 2000). Thus, Rheb might selectively induce ATF-4, but
not its downstream target, CHOP, under the experimental condi-
tions used in this study.
We then tested whether Rheb is necessary for ER-stress-
mediated phospho-eIF2a and protein synthesis. As expected,
the ER stressor tunicamycin increased phospho-eIF2a levels
and decreased the phosphorylation of an mTORC1 target,
4EBP1, in a time-dependent manner, consistent with previous
reports (Deldicque et al., 2011; Li et al., 2008), and that increase
was markedly reduced in Rheb shRNA-treated cells (Figure 2E).
While Rheb depletion (50%) did not markedly affect the [35S]
Met-incorporation in control conditions, it prevented the loss
of [35S] Met-incorporation induced by tunicamycin (Fig-
ure 2F). Thus, Rheb physiologically regulates ER-stress-induced
phospho-eIF2a levels and protein synthesis.
Rheb Induces Phosphorylation of eIF2a Independent of
mTORC1, PI3K, and MAPK Signaling
Experiments with rapamycin rule out mTOR asmediating Rheb’s
effects on phospho-eIF2a. Rapamycin virtually abolishes stimu-
lation by Rheb of phospho-S6 kinase and phospho-4EBP1 but
has negligible effects on phospho-eIF2a (Figure 3A). This finding
buttresses the conclusion that phosphorylation of eIF2a does
not involve mTORC1, consistent with previous reports (Bunpo
et al., 2009; O’Connor et al., 2008). In contrast to phosphoryla-
tion of eIF2a, which is not mediated by mTORC1, phosphoryla-
tion of other elongation factors does involve mTORC1. Thus,
rapamycin prevents phosphorylation of eIF4G and eIF4B, tar-
gets of S6K (Shahbazian et al., 2006), but not eIF2a (Figure 3B).
Kinase inhibitors provide additional evidence of specificity
(Figure 3C). Thus, wortmannin, which inhibits PI3 kinase, abol-
ishes phosphorylation of Akt and greatly reduces phospho-S6
kinase but does not alter phosphorylation of eIF2a or Erk.taining) of HEK293 cells transfected with myc or myc-Rheb WT. Tunicamycin-
xpressing myc, myc-Rheb WT, and myc-Rheb D60K.
ells.
e presence of recombinant proteins, GST (500 ng), GST-PERK-kinase domain
.
d with [35S]-Met as in (A).
.
from three experiments.
(legend on next page)
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PD98095, which inhibits the mitogen-activated protein kinase
(MAPK) pathway, greatly reduces phospho-Erk but does not in-
fluence phospho-eIF2a, phospho-Akt, or phospho-S6 kinase.
By contrast, rapamycin, as expected, abolishes phospho-S6
kinase but fails to influence phospho-eIF2a, phospho-Erk or
phospho-Akt (Figure 3C). Thus Rheb induces phosphorylation
of eIF2a independent of mTORC1, PI3K and MAPK signaling.
Rheb Elicits Phosphorylation of eIF2a via PERK
Four protein kinases are known to phosphorylate eIF2a: GCN2,
PERK, PKR, and HRI (Wek et al., 2006). Of these, GCN2 and
PERK account for the great bulk of eIF2a phosphorylation and
so have been the focus of our attention. Adenoviral-mediated
Rheb expression enhances phosphorylation of eIF2a or reduces
[35S] Met labeling comparably in GCN2 WT and GCN2-deleted
MEFs (Figures 3D and 3E). By contrast, the Rheb-mediated in-
crease in the phospho-eIF2a levels or suppression of [35S]
Met-labeling is markedly reduced in PERK deleted MEFs (Fig-
ures 3F and 3G). Rheb overexpression also increased the
viability and reduced the polysome/monosome ratio in PERK-
intact MEFs compared to PERK-deleted MEFs (Figures S5A
and S5B). In these overexpression studies, we found exoge-
nously expressed Rheb levels are 2- to 4-fold higher than endog-
enous Rheb levels. Interestingly, Rheb overexpression had no
significant effect on cell viability but decreased the proliferation
of PERK-deleted MEFs, indicating that loss of PERK might inter-
fere with Rheb’s effect on cell proliferation (Figure S5C). We also
confirmed importance of PERK in Rheb-mediated phospho-
eIF2a in HEK293 cells transiently transfected with PERK shRNA
(Figure S6). Thus, Rheb modulates phospho-eIF2a and affects
protein synthesis predominantly via PERK.
We assessed the physical association of Rheb and PERK and
how Rheb modulates PERK activity in vitro. An intimate associ-
ation of PERK and Rheb is evident in the robust binding of over-
expressed PERK with endogenous Rheb, or overexpressed
Rheb with endogenous PERK, in HEK293 cells (Figures 4A and
4B). Binding between these two proteins is direct. Rheb WT,
compared to Rheb D60K, binds strongly to PERK, as demon-
strated with purified proteins in vitro (Figure 4C).
Further evidence for the importance of Rheb in the phosphor-
ylation of eIF2a comes with PERK kinase experiments showing a
concentration-response relationship for Rheb’s stimulation of
eIF2a phosphorylation in vitro (Figure 4D). This activity is GTP
dependent, as Rheb D60K does not elicit PERK-kinase activity
in vitro (Figure 4E). This phosphorylation is selective for eIF2a-
S51, as it is abolished with S51A mutations (Figure 4F). Since
ER stress upregulated the phosphorylation of eIF2a but downre-Figure 2. Rheb Promotes the Phosphorylation of eIF2a
(A) Western blotting of indicated proteins in HEK293 cells expressing myc or my
(B) Western blotting of indicated proteins in HEK293 cells transfected with myc,
(C) Western blotting of indicated proteins in the hippocampus of adult mice over
(D) Western blotting of indicated proteins in HEK293 cells expressing Rheb shRN
(E) Western blotting of tunicamycin-treated (100 nM) control or Rheb shRNA-exp
(F) Autoradiography of [35S]-Met incorporation and total proteins (ponceau) of tu
expressing cells.
***p < 0.001; **p < 0.01; *p < 0.05; n.s, not significant (Student’s t test). Data are m
serum conditions.
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reports (Deldicque et al., 2011; Li et al., 2008), we wondered
whether this inverse signaling might occur due to an enhanced
Rheb interaction with PERK during ER stress. Although tunica-
mycin treatment abolished the Rheb-mTOR interaction, Rheb-
PERK interactions remained unaffected (Figure 4G). Thus, de-
pending upon the cellular status, such as ER stress, the Rheb-
mTOR interaction would be dismantled, but Rheb-PERK interac-
tions might be stabilized. Though this interaction may not be
increased further by ER stress, we cannot rule out the possibility
that this Rheb-PERK complex is more active under stress condi-
tions. Thus, under ER stress conditions, Rheb might selectively
associate with PERK to facilitate reduction of protein synthesis
through eIF2a signaling.
DISCUSSION
A canonical cascade for protein synthesis involves interactions
of Rheb with mTOR to activate the mTORC1 protein synthesis
pathway (Wang and Proud, 2006). In the present study, we
demonstrate an alternative pathway in which Rheb inhibits pro-
tein synthesis by stimulating the phosphorylation of eIF2a. In
terms of the overall protein synthetic activity of cells, inhibition
of protein synthesis by Rheb may be its principal role, as overex-
pressing Rheb decreases cellular protein synthesis.
The mechanism whereby Rheb inhibits protein synthesis
appears to involve enhancement of phosphorylation of eIF2a
predominantly by the PERK protein kinase. Thus, deletion of
PERK, but not another protein kinase, GCN2, markedly abol-
ishes Rheb-mediated enhancement of phospho-eIF2a. Rheb
overexpression appears to decrease extracellular regulated ki-
nase (Erk) phosphorylation, a signaling linked to protein synthe-
sis (Kelleher et al., 2004). This is consistent with previous findings
in which deletion of mTOR or Rheb elicits phosphorylation of Erk
(Carracedo et al., 2008; Kelleher et al., 2004; Li et al., 2011).
Whether Rheb-mediated reduction of Erk signaling is a feedback
loop to regulate protein synthesis remains unclear. Nevertheless,
rapamycin, which increases Erk signaling (Carracedo et al.,
2008), actually inhibits rather than promotes protein synthesis
in certain cells (Huo et al., 2011). Thus, the significance of cross-
talk between Rheb and Erk signaling and what role they play in
protein synthesis remains unclear.
Inhibition of protein synthesis in response to stressful stimuli
is a major mechanism to protect cells from stress-elicited cell
death. Phosphorylation of eIF2a by PERK is regarded as a prin-
cipal means whereby cell stress downregulates protein synthe-
sis. In the absence of cell stress, eIF2a forms a ternary complexc-Rheb WT constructs in DMEM with serum (+) or without serum ().
myc-Rheb-WT, or Rheb-D60K and processed as in (A).
expressing of AAV-Rheb or AAV-GFP.
A or control shRNA.
ressing HEK293 cells.
nicamycin-treated (100 nM) or DMSO-treated (0.5%) control or Rheb shRNA-
eans ± SEM from three experiments. Graphs in (A) and (B) are quantified from
Figure 3. Rheb Induces Phospho-eIF2a Independent of mTORC1 and Promotes Phospho-eIF2a Predominantly through PERK
(A) Western blotting of indicated proteins of HEK293 expressing cDNAs of myc (control) or myc-Rheb WT were grown in DMEM with serum (+) or without serum
() or pretreated with the inhibitors rapamycin (250 nM) or DMSO (0.5%, control).
(B) Western blotting of indicated proteins in HEK293 cells expressing myc or myc-Rheb and pretreated with rapamycin or DMSO as in (A).
(C) Western blotting of indicated proteins in HEK293 cells expressing myc or myc-Rheb and pretreated with inhibitors of MAPK (PD98059, 50 mM) or PI3K
(wortmannin, 100 nM), rapamycin, or DMSO.
(legend continued on next page)
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with tRNA and the 43S ribosome, which initiates translation (Kim-
ball, 1999). With cell stress, phosphorylation of eIF2a prevents
the formation of the ternary complex, abrogating new protein
formation.
Though Rheb is well known to activate mTOR, the physiologic
rationale for this action has not been altogether clear. Our
findings suggest that Rheb may function as a molecular switch
between stimulation and inhibition of protein synthesis (see
Graphical Abstract). Thus, by binding to mTOR kinase, Rheb
stimulates protein synthesis. On the other hand, when it binds
to PERK to enhance phosphorylation of eIF2a, protein synthesis
is inhibited. Under what cellular contexts these opposite func-
tions of Rheb are involved remains less clear. When cells are
actively growing, Rheb-mTOR circuitry might promote protein
synthesis, and when cells are under stress, for example during
uncontrolled growth, the Rheb-PERK circuitry might reduce pro-
tein synthesis. This later notion is supported by our binding ex-
periments in which we found that under ER-stress conditions
(where mTORC1 activation is reduced and P-eIF2a signaling is
increased), Rheb loses its interaction with mTOR but remains
bound to PERK (Figure 4G). As cell growth and ER stress are
intimately connected (Tsang et al., 2010), such dynamic binding
of Rheb may regulate normal physiology to reciprocally alter
mTOR and phospho-eIF2a signaling, as observed in various
cell types (Anand and Gruppuso, 2006; Deng et al., 2002; Hara
et al., 1998; Kato et al., 2012; Kim et al., 2002; Koumenis et al.,
2002; Kubota et al., 2003; Liu et al., 2006; Matsuo et al., 2005;
Schneider et al., 2008; Tee and Proud, 2001).
Our model raises the possibility that a hitherto-unidentified
posttranslational modification of Rheb—perhaps phosphoryla-
tion—mediates the reciprocity of Rheb’s capacities to stimulate
or inhibit protein synthesis. Bioinformatic analysis (GPS phos-
phorylation prediction software) indicates that Rheb possesses
several consensus sequences for phosphorylation, for example,
threonine 38 for protein kinase B, serine 130 for ribosomal S6
kinase, serine 179 for CAM kinase, and tyrosine 67 for tyrosine
kinase. Phosphorylation of Rheb at serine 130 by p38-regulated
kinase inhibits Rheb-mediated mTORC1 activation (Zheng et al.,
2011). Whether phosphorylation or other posttranslational mod-
ifications, such as acetylation, differentiate Rheb’s interactions
with mTOR versus PERK remains to be seen.
The Rheb/PERK/eIF2a system may influence major organ-
ismic activities. Recently, we found Rheb GTPase can regulate
BACE1, a principle enzyme implicated in Alzheimer’s disease
(AD) pathology (Shahani et al., 2014). PERK and phospho-
eIF2a levels are linked to BACE1 regulation and AD-related
behavioral deficits (Devi andOhno, 2010;Ma et al., 2013; O’Con-
nor et al., 2008). We also found huntingtin serves as a new
effector of Rheb GTPase to activate mTORC1 to modulate
Huntington disease (HD)-related symptoms (Pryor et al., 2014).
Though the role of phospho-eIF2a signaling in HD symptoms is(D) Western blotting of indicated proteins in GCN2/ cells and their isogeneic w
(E) Autoradiography of [35S]-Met incorporation and total protein levels (ponceau)
(F) Western blotting of indicated proteins in PERK/ cells and their isogeneic w
GTPase Rheb fails to induce P-eIF2a in PERK/ MEF cells.
(G) Autoradiography of [35S]-Met incorporation and total protein levels (ponceau
***p < 0.001; **p < 0.01; *p < 0.05; n.s, not significant (Student’s t test). Data are
690 Cell Reports 10, 684–693, February 10, 2015 ª2015 The Authorsnot clear, a recent study implicated phospho-eIF2a in HD cellular
toxicity (Leitman et al., 2014). Moreover, Rheb through phospho-
eIF2amay regulate ER stress—a feature linked to all major age-
related diseases, such as diabetes, Parkinson’s disease, AD,
and HD (Chang et al., 2002; Harding et al., 1999; Hoozemans
et al., 2007; Kang et al., 2011; Kouroku et al., 2007). Thus,
Rheb-eIF2a circuitry may have multiple cellular functions with
implications in physiological as well as pathological conditions.
EXPERIMENTAL PROCEDURES
Reagents, Plasmids, and Antibodies
Most of the reagents were purchased from Sigma, unless mentioned other-
wise. Details regarding cDNA, antibodies, viral particles, and other reagents
used can be found in the Supplemental Experimental Procedures.
Cell Culture, Transfections, and Amino Acid Treatments
HEK293 cells were grown in DMEM (Gibco 11965-092) with 10% fetal bovine
serum (FBS), 1% penicillin-streptomycin, and 5 mM glutamine. In brief, cells
were seeded in 3.5 or 6 cm plates. After 18–24 hr, the cells were transfected
with cDNA constructs using polyfect (QIAGEN) as per the manufacturer’s in-
structions. For the serum starvation protocol, after 48 hr, the growth media
was replaced with DMEM with or without 10% FBS. Cells were kept in these
media for 1–2 hr and lysed, followed by western blotting.
Immunoblotting, Coimmunoprecipitation, and In Vitro Binding
Glutathione-affinity and western blotting and in vitro binding protocols were
carried out essentially as described before (Shahani et al., 2014; Subramaniam
et al., 2009, 2010). More details can be found in the Supplemental Experi-
mental Procedures.
Cell Viability and Proliferation Assay
HEK293 cells (transfectedwith indicated vectors) or MEFs (infected with null or
Rheb adenoviruses) were grown in 24-well plates, and after 48 hr, the viability
was assessed using an MTS assay, as per the manufacturer’s protocol (Prom-
ega). For the proliferation assay, an equal number (13 104) of HEK293 cells or
MEFs were seeded in 24-well plates transfected or infected with Rheb, and
after 48 hr, cell numbers were counted using a hemocytometer.
Recombinant Protein Purification
Recombinant proteins were produced essentially as indicated before (Tyagi
et al., 2009). More information can be found in the Supplemental Experimental
Procedures.
PERK In Vitro Kinase Assay
In vitro kinase assays with recombinant bacterially expressed glutathione
S-transferase (GST)-PERK-KD or GST-PERK-DKD were performed at 30C
for 30 min in 30 ml of kinase buffer (20 mM HEPES [pH 7.5], 50 mM
KCl, 1 mM DTT, 2 mM MgCl2, 0.1 mM ATP) containing 1 mg of purified GST-
eIF2a-WT or GST-eIF2a-S51A proteins as substrate. Phosphorylation of
eIF2a was detected using western blotting with phospho-eIF2a antibody.
Where indicated, purified Rheb WT or Rheb D60K protein (50 or 100 ng) was
added to the in vitro kinase reaction.
In Vitro Translation Assay
In vitro translation assays were performed as described earlier (Harding et al.,
1999). Briefly, to measure translational inhibition by Rheb and PERK, purifiedild-type (+/+) MEFs were infected with adenovirus null or adenovirus-Rheb.
in GCN2 MEF cells infected with adenovirus null or adenovirus-Rheb.
ild-type (+/+) MEFs were infected with adenovirus null or adenovirus-Rheb.
) in PERK MEF cells infected with adenovirus null or adenovirus-Rheb.
means ± SEM from three experiments.
Figure 4. Rheb GTPase Directly Binds and Activates PERK In Vitro
(A) Western blotting/glutathione-binding affinity analysis of indicated proteins in HEK293 cells expressing GST or GST-Rheb.
(B) Western blotting analysis of immunoprecipitated (myc-IgG) proteins in HEK293 cells expressing myc or myc-PERK (and corresponding input).
(C) Western blotting of glutathione-GST affinity-purified recombinant proteins (and corresponding input) containing equimolar concentrations of untagged Rheb
WT or Rheb D60K, and GST-PERK-KD (kinase domain).
(D) Western blotting indicated proteins of in vitro PERK kinase activity containing PERK-KD with eIF2a in the absence or presence of untagged Rheb (50 and
100 ng).
(E) Western blotting indicated proteins of in vitro PERK kinase activity containing PERK-KD with eIF2a in the presence of GST-Rheb WT or GST-Rheb D60K
(100 ng).
(F) Western blotting indicated proteins of in vitro PERK kinase activity with GST-eIF2a WT and GST-eIF2a S51A.
(G) Western blotting/glutathione-binding affinity analysis of indicated protein in HEK293 cells transfected with GST or GST-Rheb in the presence of DMSO
(, 0.5%) or tunicamycin (+, 100 nM).
**p < 0.01; *p < 0.05; n.s, not significant (Student’s t test). Data are means ± SEM from three experiments.
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50 ng GST-PERK-KD or GST-PERK-DKD and 500 ng of GST-Rheb WT or
GST-Rheb-D60K were preincubated for 10 min at room temperature with
12 ml of an in vitro translation mixture (Promega) before the addition of
0.5 mg in vitro-transcribed capped luciferase mRNA. The [35S] Met-labeled
luciferase protein was resolved by 4%–12% Bis-Tris gel (Invitrogen).
Intrahippocampal AAV Injection
Mouse protocols were carried out under the guidelines approved by the Insti-
tutional Animal Care and Use Committee of The Scripps Research Institute.
Adeno-associated virus (AAV)-Rheb was stereotaxically injected into the hip-
pocampus of adult (postnatal day 90) male C57BL/6 mice, and tissue/protein
extraction and western blotting was carried out as described before (Shahani
et al., 2014).
L-[35S]-Met Labeling of HEK293 Cells
Myc (control), myc-RhebWT, or myc-Rheb D60K vectors (1 or 2 mg each) were
transfected, using polyfect, into HEK293 cells in DMEM plus 10% serum and
grown in six-well plates (Invitrogen). After 2 days, the media was replaced
with labeling media (methionine/cysteine-free DMEM media, Invitrogen)
and 100 mCi/well of [35S]-Met for 30 min, and cells were directly lysed either
in 23 Laemmli buffer with b-mercaptoethanol or in Tris buffer with 100 mg of
cycloheximide before loading onto the gels. The gels were blotted onto a poly-
vinylidene fluoride membrane, then subjected to autoradiography (Bio-Rad),
protein staining (ponceau), or the detection of phosphorylation of eIF2a and
other indicated proteins by western blotting. For tunicamycin (Tuni) experi-
ments, Tuni (100 nM) was added 3 hr before changing the medium to labeling
media with [35S]-Met.
Experiments with Mouse Embryonic Fibroblasts
TSC2/ and TSC2+/+ MEFs were from David J. Kwiatkowski (Brigham and
Women’s Hospital, Boston). PERK/ and PERK+/+ MEFs were from David
Ron (University of Cambridge, Cambridge), and GCN2/ and GCN2+/+
MEFs were from ATCC. More details can be found in the Supplemental Exper-
imental Procedures.
Polysome Profiling
Polysome profiling was essentially carried out as described before (Thoreen
et al., 2012). Formore details, see the Supplemental Experimental Procedures.
Statistical Analysis
Data were expressed as means ± SEM as indicated. All experiments were
performed at least in triplicate and repeated twice. Statistical analysis was per-
formed with a Student’s t test (Microsoft Excel).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and seven figures and can be found with this article online at http://dx.doi.
org/10.1016/j.celrep.2015.01.014.
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